Form TR-1 with annex. FSA Version 2.1 updated April 2007
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
1. Identity of the issuer or the underlying Hays Plc
issuer of existing shares to which voting
rights are attached:
2. Reason for notification (yes/no)
An acquisition or disposal of voting rights Yes
An acquisition or disposal of financial instruments which may result
in the acquisition of shares already issued to which voting rights
are attached
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) Baillie Gifford & Co
subject to notification
obligation:
4. Full name of shareholder(s)
(if different from 3):
5. Date of transaction (and 15 Dec 2008
date on which the threshold is
crossed or reached if
different):
6. Date on which issuer 16 Dec 2008
notified:
7. Threshold(s) that is/are 5%
crossed or reached:
8: Notified Details
A: Voting rights attached to shares
Class/type Situation Resulting situation after the triggering
of shares previous to the transaction
triggering
If possible transaction
use ISIN
code
Number of Number of Number Number of voting Percentage of voting
shares voting of rights rights
rights shares
Direct Indirect Direct Indirect
Ordinary 83,300,667 6.05 82,159,543 0 82,159,543 5.97
Share
GB0004161021
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ No. of voting Percentage of
financial date conversion rights that may be voting rights
instrument period/date acquired (if the
instrument
exercised/
converted)
N/A
Total (A+B)
Number of voting rights Percentage of voting rights
82,159,543 5.97
9. Chain of controlled undertakings through which the voting rights and /or the
financial instruments are effectively held, if applicable:
In the narrative below, the figures in [ ] indicate the amount of voting rights
and the percentage held by each controlled undertaking where relevant.
Baillie Gifford & Co, a discretionary investment manager, is the parent
undertaking of an investment management group.
Its wholly-owned subsidiary undertaking Baillie Gifford Overseas Limited
[11,618,945; 0.8%] is also a discretionary investment manager.
Its wholly-owned subsidiary undertaking Baillie Gifford & Co Limited
[1,092,403; 0.1%] is an OEIC Authorised Corporate Director and Unit Trust
Manager which has delegated its discretionary investment management role to
Baillie Gifford & Co.
Its wholly-owned subsidiary undertaking Baillie Gifford Life Limited
[12,248,739; 0.9%] is a life assurance company which procures discretionary
investment management services from Baillie Gifford & Co in respect of its own
account shareholdings.
Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy
holder will cease to hold:
12. Date on which proxy holder will
cease to hold voting rights:
13. Additional information:
14 Contact name: Stefan Bort
15. Contact telephone name: 020 7391 6640
For notes on how to complete form TR-1 please see the FSA website.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.